about
A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic ConstipationThe human endolymphatic sac expresses natriuretic peptides.Emerging treatments in Neurogastroenterology: Perspectives of guanylyl cyclase C agonists use in functional gastrointestinal disorders and inflammatory bowel diseases.Use of a Targeted Urine Proteome Assay (TUPA) to identify protein biomarkers of delayed recovery after kidney transplant.Metabolic responses to xenin-25 are altered in humans with Roux-en-Y gastric bypass surgeryProlonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation.An activating gucy2c mutation causes impaired contractility and fluid stagnation in the small bowel.
P2860
Q33634439-249381B9-6B0D-4FDE-8003-C31B2444C210Q38906947-1345DDF9-C1BD-4877-8DDB-C688B63DF3FDQ39012302-AD29AF69-016B-496B-9B6C-D09415117E10Q40307249-4AECB0E3-8754-408B-AE66-5BF903345655Q42141028-AD630DBE-42F9-4E96-AFD8-6E48E3D6DED0Q42366248-51BE4D2F-F2DC-4BF9-BB1C-DCE0A3DA65F7Q51282812-6EFA27FA-290E-4A8D-9338-F6C099985E7B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current understanding of guanylin peptides actions.
@en
type
label
Current understanding of guanylin peptides actions.
@en
prefLabel
Current understanding of guanylin peptides actions.
@en
P2860
P356
P1433
P1476
Current understanding of guanylin peptides actions
@en
P2093
Aleksandra Sindic
P2860
P304
P356
10.5402/2013/813648
P577
2013-04-17T00:00:00Z